Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.45 |
| ▸ | DAO | P14920 | 1/20 | 0.45 |
| ▸ | PARP1 | P09874 | 5/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17597734 | 0.98 | CA12 (0.46) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL17595029 | 0.98 | CA12 (0.46) | CA12CA1CA2CA7CA9 | |
| Terephthalamide SCHEMBL15399897 | 0.88 | TYK2 (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2826027 | 0.81 | DAO (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1643442 | 0.79 | DAO (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL26619127 | 0.78 | NAPRT (0.55) | NAPRTDAOPARP1KDM4EALDH1A1 | |
| SCHEMBL17029566 | 0.78 | DAO (0.41) | CA12CA1CA9NAPRTDAO | |
| SCHEMBL2223763 | 0.77 | NOTUM (0.45) | NAPRTDAOPARP1KDM4EALDH1A1 | |
| SCHEMBL3653849 | 0.77 | DPP4 (0.47) | NAPRTKDM4EALDH1A1HSD17B10TDP1 | |
| SCHEMBL3648576 | 0.77 | NAPRT (0.44) | NAPRTDAOPARP1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12002595-B2 | Separation of metal ions by liquid-liquid extraction | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-04 | — | — | US | claimed |
| EP-3107580-B1 | USE OF A REVERSE-MICELLAR SYSTEM FOR DELIVERING CHELATORS OF RADIONUCLIDES AND METALS | MEDESIS PHARMA (FR) | 2024-02-14 | — | — | EP | claimed |
| US-20240000832-A1 | TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE | MEDESIS PHARMA (FR) | 2024-01-04 | — | — | US | claimed |
| EP-4290532-A2 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | The Regents of the University of California (US) | 2023-12-13 | — | — | EP | claimed |
| EP-3520117-B1 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | UNIV CALIFORNIA (US) | 2023-11-08 | — | — | EP | claimed |
| US-20210315931-A1 | TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE | MEDESIS PHARMA (FR) | 2021-10-14 | — | — | US | claimed |
| EP-3817725-A1 | TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE | Medesis Pharma (FR) | 2021-05-12 | — | — | EP | claimed |
| EP-3615077-A1 | ACUTE AND CHRONIC MITOCHONDRIAL ELECTRON TRANSPORT CHAIN DYSFUNCTION TREATMENTS AND GRAPHENIC MATERIALS FOR USE THEREOF | William Marsh Rice University (US) | 2020-03-04 | — | — | EP | claimed |
| WO-2020008032-A1 | TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE | MEDESIS PHARMA (FR) | 2020-01-09 | — | — | WO | claimed |
| US-20190287691-A1 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-09-19 | — | — | US | claimed |
| US-20140271825-A1 | PHARMACEUTICAL FORMULATIONS OF CHELATING AGENTS AS A METAL REMOVAL TREATMENT SYSTEM | ZONEONE PHARMA, INC. | 2014-09-18 | — | — | US | claimed |
| EP-2750504-A1 | ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE | PTC Therapeutics, Inc. (US) | 2014-07-09 | — | — | EP | claimed |
| WO-2013033258-A1 | ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE | PTC THERAPEUTICS, INC. (US) | 2013-03-07 | — | — | WO | claimed |
| US-20100317117-A1 | SELECTIVE MEMBRANE EXTRACTION OF RADIOACTIVE ANALYTES | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2010-12-16 | — | — | US | claimed |
| EP-1423399-A4 | HYDROXYPYRIDONATE AND HYDROXYPYRIMIDINONE CHELATING AGENTS | UNIV CALIFORNIA (US) | 2008-05-07 | — | — | EP | claimed |
| US-6846915-B2 | Hydroxypyridonate and hydroxypyrimidinone chelating agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-01-25 | — | — | US | claimed |
| US-20050008570-A1 | Hydroxypyridonate and hydroxypyrimidinone chelating agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-01-13 | — | — | US | claimed |
| EP-1423399-A2 | HYDROXYPYRIDONATE AND HYDROXYPYRIMIDINONE CHELATING AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-06-02 | — | — | EP | claimed |
| US-20030095922-A1 | Hydroxypyridonate and hydroxypyrimidinone chelating agents | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-05-22 | — | — | US | claimed |
| WO-2003016923-A2 | HYDROXYPYRIDONATE AND HYDROXYPYRIMIDINONE CHELATING AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-02-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190287691-A1 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | SLC39A14, SLC39A11, SLC39A7 | CA12 351/4885CA1 243/4885CA2 18/4885 |
| US-20050008570-A1 | Hydroxypyridonate and hydroxypyrimidinone chelating agents | HAMP, GDI1, MPI | CA12 920/4885CA1 416/4885CA2 272/4885 |
| US-20210315931-A1 | TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE | MRE11, TSG101, CTSA | CA12 1615/4885CA1 2491/4885CA2 3701/4885 |
| US-12002595-B2 | Separation of metal ions by liquid-liquid extraction | SLC39A14, SLC39A11, SLC39A7 | CA12 351/4885CA1 243/4885CA2 18/4885 |
| US-20240000832-A1 | TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE | MRE11, TSG101, CTSA | CA12 1615/4885CA1 2491/4885CA2 3701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.